Market Place
Sourcing Support
Verily Receives Research Grant for Parkinson`s Molecular Dataset
30 Apr 2025 //
BUSINESSWIRE
Former Verily execs launch effort to transform clinical trials
10 Sep 2024 //
ENDPTS
Verily to relocate its HQ from San Francisco to Dallas
30 Jul 2024 //
FIERCE BIOTECH
A conversation with CMSO Andrew Trister on Verily`s new focus
15 May 2024 //
FIERCE BIOTECH
Otsuka Works with Verily to Launch Longitudinal Mental Health Registry
04 Apr 2024 //
BUSINESSWIRE
Verily’s chief medical officer Amy Abernethy is stepping down
19 Dec 2023 //
ENDPTS
Georgiamune and Verily Announce Partnership to Advance Novel Cancer Treatment
26 Oct 2023 //
BUSINESSWIRE
Verily launches Viewpoint Workbench to unify data
05 Oct 2023 //
BUSINESSWIRE
Letter of the day for Alphabet`s Verily is O for OneOncology
17 Aug 2023 //
FIERCE BIOTECH
Verily welcomes Atara Biotherapeutics veteran as new CFO
08 Feb 2023 //
ENDPTS
Verily narrows focus, cutting device work and laying off staff
12 Jan 2023 //
FIERCE BIOTECH
Verily``s Onduo slashes blood sugar in Type 2 diabetes patients
07 Nov 2022 //
FIERCEBIOTECH
Verily to build data-powered registry of IBD patients
25 Oct 2022 //
FIERCEBIOTECH
Verily hooks $1B round amid C-suite shuffle
13 Sep 2022 //
ENDPTS
Verily, iRhythm garner ECG smartwatch AI clearances from FDA
25 Jul 2022 //
FIERCEBIOTECH
Sosei Heptares and Verily to collaborate on immune-mediated disease treatments
06 Jan 2022 //
PHARMATIMES
Inside Verily’s make-or-break push to turn its most promising ideas into profits
08 Sep 2021 //
STAT NEWS
Amy Abernethy to handle the clinical trial management platform at Verily.
18 Aug 2021 //
ENDPOINTS
Verily logs first major buy, adding to Baseline trial platform
17 Aug 2021 //
FIERCEBIOTECH
Verily launches healthcare AI research center in Israel
05 Aug 2021 //
FIERCEBIOTECH
FDA nixes Verily’s request to add Parkinson`s exam to smartwatch
08 Jun 2021 //
FIERCEBIOTECH
iRhythm links with Verily to help diagnose ‘silent’ AFib cases
06 Sep 2019 //
FIERCEBIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.